Eleonora Gianti

According to our database, Eleonora Gianti authored at least 5 papers between 2008 and 2016.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2016

Computational analysis of EBNA1 "druggability" suggests novel insights for Epstein-Barr virus inhibitor design.

Eleonora Gianti, Troy E. Messick, Paul M. Lieberman, Randy J. Zauhar

J. Comput. Aided Mol. Des., 2016

2015

An SH2 domain model of STAT5 in complex with phospho-peptides define "STAT5 Binding Signatures".

Eleonora Gianti, Randy J. Zauhar

J. Comput. Aided Mol. Des., 2015

2013

Fragment-based Shape Signatures: a new tool for virtual screening and drug discovery.

Randy J. Zauhar, Eleonora Gianti, William J. Welsh

J. Comput. Aided Mol. Des., 2013

2012

Modeling Androgen Receptor Flexibility: A Binding Mode Hypothesis of CYP17 Inhibitors/Antiandrogens for Prostate Cancer Therapy.

Eleonora Gianti, Randy J. Zauhar

J. Chem. Inf. Model., 2012

2008

Identification and Selection of "Privileged Fragments" Suitable for Primary Screening.

Eleonora Gianti, Luca Sartori

J. Chem. Inf. Model., 2008